IRF8 and acute myeloid leukemia: Besides these already known factors involved in AML progression, we also identified several novel candidates, including the interferon regulatory factor 8 (IRF8, also ICSBP) (Figure 1D), which has been described as a tumor suppressor in several other cancer types before [12,13,14,15,16,17,18].